Sleep Deprivation

The grounding supports sleep deprivation as arising from experimental sleep loss, life events, and a range of pathophysiologic causes. These include medication effects, chronic illness, psychiatric illness, and sleep disorders.

Sleep deprivation disrupts sleep homeostasis and circadian physiology and is associated with altered REM sleep-related mechanisms. It affects immune function, producing changes in innate and adaptive immunity and a chronic inflammatory state, and it can also alter metabolic and redox processes. In the nervous system, it impairs clearance of misfolded proteins through cellular and glymphatic pathways, contributing to neuroinflammation, oxidative stress, and cognitive decline.

Reduced sleep duration below recommended ranges is a general risk context for sleep deprivation. The grounding also supports medication effects, chronic illness, psychiatric illness, and sleep disorders as factors associated with developing sleep deprivation. Life events that reduce sleep opportunity are another risk context.

The supplied grounding does not describe a specific treatment standard for sleep deprivation. It supports the concept that management is generally directed at the underlying cause, such as medication effects, chronic illness, psychiatric illness, or sleep disorders, rather than a disease-specific drug class or modality.